{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:21:24Z","timestamp":1778595684267,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["H25-Iryogijutsu-Shitei-012"],"award-info":[{"award-number":["H25-Iryogijutsu-Shitei-012"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP15fk0108046h0003"],"award-info":[{"award-number":["JP15fk0108046h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108095"],"award-info":[{"award-number":["JP19fk0108095"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jiac.2021.03.001","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T23:48:15Z","timestamp":1615679295000},"page":"924-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Primaquine plus clindamycin as a promising salvage therapy for Pneumocystis jirovecii pneumonia: A retrospective analysis in Japanese patients"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3122-9735","authenticated-orcid":false,"given":"Michiko","family":"Koga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-0262","authenticated-orcid":false,"given":"Kensuke","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Takezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.03.001_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia","volume":"96","author":"Salzer","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.jiac.2021.03.001_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2165\/00002018-199005030-00006","article-title":"A\u00a0risk-benefit analysis","volume":"5","author":"Wispelwey","year":"1990","journal-title":"Drug Saf"},{"key":"10.1016\/j.jiac.2021.03.001_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2310\/7060.2003.31775","article-title":"Epidemiological and clinical aspects of malaria in Japan","volume":"10","author":"Kimura","year":"2003","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.jiac.2021.03.001_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tmaid.2014.11.005","article-title":"Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers \u2013 a retrospective analysis","volume":"13","author":"Shimizu","year":"2015","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.jiac.2021.03.001_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(89)92446-X","article-title":"Clindamycin with primaquine for Pneumocystis carinii pneumonia","author":"Toma","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2021.03.001_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00007611-199004000-00010","article-title":"Clindamycin\/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS","volume":"83","author":"Kay","year":"1990","journal-title":"South Med J"},{"key":"10.1016\/j.jiac.2021.03.001_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinids\/14.1.183","article-title":"Salvage therapy with clindamycin\/primaquine for Pneumocystis carinii pneumonia","volume":"14","author":"Noskin","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.03.001_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","article-title":"Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine","volume":"124","author":"Safrin","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2021.03.001_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1086\/514696","article-title":"Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind randomized trial (CTN 004)","volume":"27","author":"Toma","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.03.001_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10156-009-0710-Z","article-title":"Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia","volume":"15","author":"Kim","year":"2009","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2021.03.001_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAI.0b013e31816de84d","article-title":"Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia. A case series and systematic review","volume":"48","author":"Benfield","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2021.03.001_bib12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jac\/dkp372","article-title":"Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study","volume":"64","author":"Helweg-Larsen","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2021.03.001_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s15010-014-0660-y","article-title":"Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients","volume":"42","author":"Nickel","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2021.03.001_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/clinids\/17.2.178","article-title":"Clindamycin\/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial","volume":"17","author":"Toma","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.03.001_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","article-title":"Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"Taylor","year":"2019","journal-title":"Lancet"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:40Z","timestamp":1778594140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1341321X21000702"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.03.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primaquine plus clindamycin as a promising salvage therapy for Pneumocystis jirovecii pneumonia: A retrospective analysis in Japanese patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}